神経因性疼痛の世界市場：薬剤クラス別、適応症別、流通チャネル別、地域別－規模、シェア、展望、機会分析（2022年～2028年）

FDAが承認した薬剤の数が少ない、痛みの緩和が不完全であるなどの要因が、世界の神経因性疼痛市場の成長を抑制すると予想されます。

当レポートでは、世界の神経因性疼痛市場について調査しており、市場展望、市場力学、市場分析、競合情勢など、包括的な情報を提供しています。

目次

第1章 調査目的・前提条件

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
  • 市場の内訳：製品タイプ別
  • 市場の内訳：エンドユーザー別
  • 市場の内訳：地域別
  • コヒーレントオポチュニティマップ（COM）

第3章 市場力学、規制、および動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 市場機会
• 影響分析
• 主なハイライト
• 製品発売
• PEST分析
• 規制シナリオ
• 合併と買収

第4章 世界の神経因性疼痛市場：製品タイプ別（100万米ドル）（2017年～2028年）

• イントロダクション
• 体温調節装置
• 光療法機器
• 新生児新生児モニタリングシステム
• 聴力検査
• 視力検査

第5章 世界の神経因性疼痛市場：エンドユーザー別（100万米ドル）（2017年～2028年）

• イントロダクション
• 病院
• 小児・新生児クリニック
• 養護施設

第6章 世界の神経因性疼痛市場：地域別（100万米ドル）（2017年～2028年）

• イントロダクション
• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第7章 競合情勢

• 企業プロファイル
  • GE Healthcare
  • Koninklijke Philips NV
  • Medtronic plc
  • Dragerwerk AG &Co. KgaA
  • Natus Medical Incorporated
  • Pluss Advanced Technologies Pvt. Ltd.
  • Weyer GmbH
  • Fisher &Paykel Healthcare Limited
  • Ba:ByBloom Healthcare BV
  • Novos Medical Systems
  • Medical Technology Transfer and Services Asia(MTTS Asia)
  • Inspiration Healthcare Group plc.
  • Fanem Ltda.

第8章 セクション

Neuropathic pain is a condition which involves pain caused due to damage or diseases affecting the nervous system. These conditions may include diseases such as diabetes causing diabetic neuropathy, chemotherapy induced neuropathic pain, and trigeminal neuralgia. Diabetic neuropathy is the damage caused to the nerve due to diabetes which often leads to pain and numbness in feet or lower legs. The pain can be experienced in other parts of the body such as hips, wrist and back depending upon the effect of neuropathy. There are different types of neuropathy such as focal neuropathy, proximal neuropathy, peripheral neuropathy and autonomic neuropathy. An estimated 50% of diabetic population suffers from diabetic neuropathy across the globe. Further, as per CDC estimates, 6-7 people per 1000 diabetic population suffer from diabetic neuropathy in the U.S.

Restraints of the Global Neuropathic Pain Market

Factors such as availability of less number of FDA approved medications, and incomplete pain relief, are expected to restrain growth of the global neuropathic pain market.

Key features of the study:

This report provides in-depth analysis of the global neuropathic pain market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players

It profiles leading players in the global neuropathic pain market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans

Key companies covered as a part of this study include Pfizer, Inc., Johnson & Johnson Services, Inc., Sanofi S.A., Eliy Lily and Company, GlaxoSmithKline PLC, Biogen Idec., Bristol-Myers Sqibb, Baxter Healthcare Corporation, and Depomed, Inc.

Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics

The global neuropathic pain market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

Global Neuropathic Pain Market, By Drug Class:

Tricyclic Anti-Depressant

Anticonvulsant

Local Anaesthesia

Opioids

Steroids

Others

Global Neuropathic Pain Market, By Indication:

Diabetic neuropathy

Chemotherapy-induced Peripheral neuropathy

Other

Global Neuropathic Pain Market, By Distribution Channel:

Retail Pharmacies

Drug Store

Online Pharmacies

Global Neuropathic Pain Market, By Geography:

North America

By Drug Class

Tricyclic Anti-Depressant

Anticonvulsant

Local Anaesthesia

Opioids

Steroids

Others

By Indication

Diabetic neuropathy

Chemotherapy-induced Peripheral neuropathy

Other

By Distribution Channel

Retail Pharmacies

Drug Store

Online Pharmacies

By Country:

U.S.

Canada

Europe

By Drug Class

Tricyclic Anti-Depressant

Anticonvulsant

Local Anaesthesia

Opioids

Steroids

Others

By Indication

Diabetic neuropathy

Chemotherapy-induced Peripheral neuropathy

Other

By Distribution Channel

Retail Pharmacies

Drug Store

Online Pharmacies

By Country:

U.K.

Germany

Italy

France

Spain

Russia

Rest of Europe

Asia Pacific

By Drug Class

Tricyclic Anti-Depressant

Anticonvulsant

Local Anaesthesia

Opioids

Steroids

Others

By Indication

Diabetic neuropathy

Chemotherapy-induced Peripheral neuropathy

Other

By Distribution Channel

Retail Pharmacies

Drug Store

Online Pharmacies

By Country:

China

India

Japan

ASEAN

Australia

South Korea

Rest of Asia Pacific

Latin America

By Drug Class

Tricyclic Anti-Depressant

Anticonvulsant

Local Anaesthesia

Opioids

Steroids

Others

By Indication

Diabetic neuropathy

Chemotherapy-induced Peripheral neuropathy

Other

By Distribution Channel

Retail Pharmacies

Drug Store

Online Pharmacies

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Middle East:

By Drug Class

Tricyclic Anti-Depressant

Anticonvulsant

Local Anaesthesia

Opioids

Steroids

Others

By Indication

Diabetic neuropathy

Chemotherapy-induced Peripheral neuropathy

Other

By Distribution Channel

Retail Pharmacies

Drug Store

Online Pharmacies

By Country:

GCC

Israel

Rest of Middle East

Africa

By Drug Class

Tricyclic Anti-Depressant

Anticonvulsant

Local Anaesthesia

Opioids

Steroids

Others

By Indication

Diabetic neuropathy

Chemotherapy-induced Peripheral neuropathy

Other

By Distribution Channel

Retail Pharmacies

Drug Store

Online Pharmacies

By Country/Region:

Central Africa

South Africa

North Africa

Company Profiles

Pfizer, Inc.*

Company Overview

Product Portfolio

Financial Performance

Key Strategies

Recent Developments

Johnson & Johnson Services, Inc.

Sanofi S.A.

Eily Lily and Company

GlaxoSmithKline PLC

Biogen Idec.

Bristol-Myers Squibb

Baxter Healthcare Corporation

Depomed, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By End User
  • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Key Highlights
• Product launch
• PEST Analysis
• Regulatory Scenario
• Mergers and Acquisitions

4. Global Neonatal Infant Care Equipment Market, By Product Type, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Thermoregulation Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Radiant Warmers
  • Neonatal Incubators
  • Neonatal Cooling Systems
• Phototherapy Equipment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • LED Phototherapy Unit
  • CFL Phototherapy Unit
  • Phototherapy Eye Mask
• Neonates Neonatal Monitoring Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Neonatal Ventilation
  • Brain Monitoring
  • Blood Gas Monitoring System
• Hearing Screening
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Vision Screening
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

5. Global Neonatal Infant Care Equipment Market, By End User, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Pediatric and Neonatal Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Nursing Homes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Neonatal Infant Care Equipment Market, By Region, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
• North America
  • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • U.S.
  • Canada
• Latin America
  • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of APAC
• Middle East
  • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

7. Competitive Landscape

• Company Profiles
  • GE Healthcare
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Koninklijke Philips N.V.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Medtronic plc
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Dragerwerk AG & Co. KgaA
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Natus Medical Incorporated
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Pluss Advanced Technologies Pvt. Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Weyer GmbH
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Fisher & Paykel Healthcare Limited
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • BabyBloom Healthcare BV
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Novos Medical Systems
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Medical Technology Transfer and Services Asia (MTTS Asia)
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Inspiration Healthcare Group plc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Fanem Ltda.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies

8. Section

• References
• Research Methodology
• About us and Sales Contact